Basic Science Catalyzing Treatments for Glaucoma

青光眼的基础科学催化治疗

• 批准号: 9391815
• 负责人: W Daniel Stamer
• 金额: $ 2.41万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-01 至 2018-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9391815
• 关键词: Academia; Area; Award; Back; Basic Science; Blindness; Cellular biology; Clinical; Clinical Research; Collaborations; Development; Diagnosis; Disease; Disease Progression; Doctor of Medicine; Doctor of Philosophy; Environment; Ethnic group; Eye; Feedback; Fellowship; Foundations; Functional disorder; Funding; Future; Gene Mutation; Glaucoma; Goals; Homeostasis; Individual; Industry; Institution; International; Knowledge; Learning; Location; Mind; Molecular; Monitor; Morehouse School of Medicine; Natural regeneration; Ophthalmologist; Optic Disk; Participant; Pathogenesis; Pathology; Patient Care; Patients; Physiologic Intraocular Pressure; Public Health; Recording of previous events; Recruitment Activity; Research; Research Personnel; Resources; Retinal Ganglion Cells; Scientist; Secure; Senior Scientist; Societies; Structure; Students; Therapeutic; Tissues; Translating; Translational Research; Translations; Travel; Underrepresented Minority; Universities; Vision; Woman; Work; career; career development; cell injury; educational atmosphere; ethnic diversity; imaging modality; interest; lectures; meetings; neuroprotection; new technology; novel; posters; role model; social; student participation; symposium; translational impact

Summary This proposal seeks support for the 2017 International Society for Eye Research (ISER)-BrightFocus Foundation (BFF) glaucoma meeting titled "Basic Science Catalyzing Treatments for Glaucoma" to be held October 5th – 7th, 2017 in Atlanta, Georgia at the Emory Conference Center Hotel. As with the inaugural meeting that was held in Sarasota, FL in 2013, the goal of this meeting is to bring together basic scientists, clinician-scientists, students and fellows for presentations and in-depth discussions on the molecular mechanisms that underlie glaucomatous pathology, both at the level of the conventional outflow tract and optic nerve head. Additionally, novel technologies developed (i) to diagnose and monitor disease progression, (ii) modify/restore glaucomatous dysfunction and (ii) regenerate damaged cells/tissues will be presented. We have already recruited 6 thought leaders in glaucoma to give keynote lectures at the conference. As with the first meeting, the eleven platform sessions will be selected exclusively from submitted abstracts. We have reserved one of the platform sessions and we are putting on a one-day "crash course" in glaucoma exclusively for junior investigators, consistent with our goal of increasing student and junior investigator participation. ISER and BFF have an established history for promoting diversity, and the speakers that are selected from abstracts will represent a diverse group of scientists that includes women and underrepresented individuals. The Specific Aims of the conference are: 1. To enhance the emerging careers of 22 young scientists (including women and underrepresented minorities) in glaucoma and increase student participation in the meeting by providing travel awards. 2. To provide a forum for dissemination of the most recent advances in the state of knowledge on glaucoma. 3. To create an environment that will facilitate the exchange of novel ideas among basic and clinician scientists and generate the opportunity for vision scientists of all ethnic groups and social backgrounds to meet and establish research collaborations. 4. To bring together scientists working in disparate areas of glaucoma research. We anticipate that this meeting will provide useful information on recent advances in glaucoma and will serve as an important resource for those involved in the translation of these findings into suitable therapeutics. This conference will also provide new opportunities, avenues for new discovery, and a forum to develop potential collaborations among the attendees. The requested funds will support the travel, accommodation and registration of 12 students (pre- and postdoctoral) and 10 junior investigators who otherwise would not have the resources to attend this focused meeting.

总结 该提案寻求对2017年国际眼科研究学会（ISER）的支持。 基金会（BFF）青光眼会议题为“基础科学催化青光眼治疗”将举行 2017年10月5日至7日在亚特兰大，格鲁吉亚在埃默里会议中心酒店。与就职典礼一样， 会议于2013年在佛罗里达州萨拉索塔举行，这次会议的目标是汇集基础科学家， 临床医生，科学家，学生和研究员的介绍和深入讨论的分子 在常规流出道水平和常规流出道水平， 视神经头此外，开发了新技术（i）诊断和监测疾病 进展，（ii）修饰/恢复昏迷性功能障碍和（ii）再生受损的细胞/组织， 提出了我们已经招募了6位青光眼领域的思想领袖， 会议与第一次会议一样，11个平台会议将专门从 提交摘要。我们已经预订了一个平台会议，我们正在进行为期一天的“崩溃 课程”青光眼专门为初级研究人员，符合我们的目标，增加学生和 初级研究者参与。ISER和BFF在促进多样性方面有着悠久的历史， 从摘要中选出的发言者将代表包括妇女在内的各种科学家群体 和代表性不足的个人。 会议的具体目标是： 1.加强22名青年科学家（包括女性和代表性不足的科学家）的新兴职业 会议还通过提供旅行奖励来提高学生对会议的参与。 2.提供一个论坛，传播关于以下方面的最新知识进展： 青光眼 3.创造一个环境，促进基础和临床医生之间交流新的想法 科学家，并为所有种族和社会的视觉科学家创造机会 背景，以满足和建立研究合作。 4.聚集在青光眼研究不同领域的科学家。 我们预计，这次会议将提供有用的信息，在青光眼的最新进展，并将服务于 作为参与将这些发现转化为合适疗法的人的重要资源。 本次会议还将提供新的机会，新发现的途径，以及发展的论坛。 与会者之间的潜在合作。申请的资金将用于支付差旅费、住宿费、 和注册12名学生（前和博士后）和10名初级研究人员，否则他们不会 有足够的资源来参加这次重点会议。